SRIVASTAVA, BRIJESH K.,DESAI, RANJIT C.,PATEL, PANKAJ R.
申请号:
CA2890309
公开号:
CA2890309A1
申请日:
2013.12.23
申请国别(地区):
CA
年份:
2014
代理人:
摘要:
The present invention relates to novel compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process of preparing novel compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis. The compounds of formula (I) are useful as PARP-1 inhibitors for the treatment of, e.g. cancer.